A powerful consortium of research organizations in Europe speaks out against a recent ruling to ban patenting of research on human embryonic stem cells.
The Scientist
Most Recent
Japanese researchers are launching an iPS cell trial for an untreatable eye disease, challenging ongoing embryonic stem cell trials.
Researchers identify common genetic changes in cultured human embryonic stem cells, including one that confers a growth advantage.
Geron is terminating a clinical trial testing a human embryonic stem cell treatment for spinal cord injury.
Following last week’s ruling by the European Court of Justice that research procedures involving human embryonic stem cells cannot be patented, European researchers, lawyers, and investors are striving to put a positive spin on the decision. "If anyt
The high court in Europe decided that researchers are barred from filing EU patents on work involving human embryonic stem cells.
A breakthrough in somatic cell nuclear transfer opens the possibility of producing human embryonic stem cells with a patient’s own genes.
The US company investigating the use of human embryonic stem cells to treat a type of macular dystrophy expands its clinical trials to the UK.
Two scientists have appealed the ruling to allow federal funding of human embryonic stem cell research.
Researchers are developing ways to convert mature somatic cells from one cell type to another, avoiding the tumor-causing pluripotent stage associated with stem cells.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
